The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis

Ali Nowrouzi, Wing T. Cheung, Tingting Li, Xuegong Zhang, Anne Arens, Anna Paruzynski, Simon N. Waddington, Emma Osejindu, Safia Reja, Christof Von Kalle, Yoahe Wang, Faisal Al-Allaf, Lisa Gregory, Matthew Themes, Maxine Holder, Niraja Dighe, Alaine Ruthe, Suzanne M K Buckley, Brian Bigger, Eugenio MontiniAdrian J. Thrasher, Robert Andrews, Terry P. Roberts, Robert F. Newbold, Charles Coutelle, Manfred Schmidt, Mike Themis

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Genotoxicity models are extremely important to assess retroviral vector biosafety before gene therapy. We have developed an in utero model that demonstrates that hepatocellular carcinoma (HCC) development is restricted to mice receiving nonprimate (np) lentiviral vectors (LV) and does not occur when a primate (p) LV is used regardless of woodchuck post-translation regulatory element (WPRE) mutations to prevent truncated X gene expression. Analysis of 839 npLV and 244 pLV integrations in the liver genomes of vector-treated mice revealed clear differences between vector insertions in gene dense regions and highly expressed genes, suggestive of vector preference for insertion or clonal outgrowth. In npLV-associated clonal tumors, 56% of insertions occurred in oncogenes or genes associated with oncogenesis or tumor suppression and surprisingly, most genes examined (11/12) had reduced expression as compared with control livers and tumors. Two examples of vector-inserted genes were the Park 7 oncogene and Uvrag tumor suppressor gene. Both these genes and their known interactive partners had differential expression profiles. Interactive partners were assigned to networks specific to liver disease and HCC via ingenuity pathway analysis. The fetal mouse model not only exposes the genotoxic potential of vectors intended for gene therapy but can also reveal genes associated with liver oncogenesis.

Original languageEnglish
Pages (from-to)324-337
Number of pages14
JournalMolecular Therapy
Volume21
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Mutagenesis
Carcinogenesis
Liver
Genes
Oncogenes
Genetic Therapy
Hepatocellular Carcinoma
Marmota
Neoplasms
Insertional Mutagenesis
Tumor Suppressor Genes
Primates
Liver Diseases
Genome
Gene Expression
Mutation

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Genetics
  • Drug Discovery
  • Pharmacology

Cite this

The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis. / Nowrouzi, Ali; Cheung, Wing T.; Li, Tingting; Zhang, Xuegong; Arens, Anne; Paruzynski, Anna; Waddington, Simon N.; Osejindu, Emma; Reja, Safia; Von Kalle, Christof; Wang, Yoahe; Al-Allaf, Faisal; Gregory, Lisa; Themes, Matthew; Holder, Maxine; Dighe, Niraja; Ruthe, Alaine; Buckley, Suzanne M K; Bigger, Brian; Montini, Eugenio; Thrasher, Adrian J.; Andrews, Robert; Roberts, Terry P.; Newbold, Robert F.; Coutelle, Charles; Schmidt, Manfred; Themis, Mike.

In: Molecular Therapy, Vol. 21, No. 2, 02.2013, p. 324-337.

Research output: Contribution to journalArticle

Nowrouzi, A, Cheung, WT, Li, T, Zhang, X, Arens, A, Paruzynski, A, Waddington, SN, Osejindu, E, Reja, S, Von Kalle, C, Wang, Y, Al-Allaf, F, Gregory, L, Themes, M, Holder, M, Dighe, N, Ruthe, A, Buckley, SMK, Bigger, B, Montini, E, Thrasher, AJ, Andrews, R, Roberts, TP, Newbold, RF, Coutelle, C, Schmidt, M & Themis, M 2013, 'The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis', Molecular Therapy, vol. 21, no. 2, pp. 324-337. https://doi.org/10.1038/mt.2012.224
Nowrouzi, Ali ; Cheung, Wing T. ; Li, Tingting ; Zhang, Xuegong ; Arens, Anne ; Paruzynski, Anna ; Waddington, Simon N. ; Osejindu, Emma ; Reja, Safia ; Von Kalle, Christof ; Wang, Yoahe ; Al-Allaf, Faisal ; Gregory, Lisa ; Themes, Matthew ; Holder, Maxine ; Dighe, Niraja ; Ruthe, Alaine ; Buckley, Suzanne M K ; Bigger, Brian ; Montini, Eugenio ; Thrasher, Adrian J. ; Andrews, Robert ; Roberts, Terry P. ; Newbold, Robert F. ; Coutelle, Charles ; Schmidt, Manfred ; Themis, Mike. / The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis. In: Molecular Therapy. 2013 ; Vol. 21, No. 2. pp. 324-337.
@article{8c92bcf41c484b9b85a692eb95788e07,
title = "The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis",
abstract = "Genotoxicity models are extremely important to assess retroviral vector biosafety before gene therapy. We have developed an in utero model that demonstrates that hepatocellular carcinoma (HCC) development is restricted to mice receiving nonprimate (np) lentiviral vectors (LV) and does not occur when a primate (p) LV is used regardless of woodchuck post-translation regulatory element (WPRE) mutations to prevent truncated X gene expression. Analysis of 839 npLV and 244 pLV integrations in the liver genomes of vector-treated mice revealed clear differences between vector insertions in gene dense regions and highly expressed genes, suggestive of vector preference for insertion or clonal outgrowth. In npLV-associated clonal tumors, 56{\%} of insertions occurred in oncogenes or genes associated with oncogenesis or tumor suppression and surprisingly, most genes examined (11/12) had reduced expression as compared with control livers and tumors. Two examples of vector-inserted genes were the Park 7 oncogene and Uvrag tumor suppressor gene. Both these genes and their known interactive partners had differential expression profiles. Interactive partners were assigned to networks specific to liver disease and HCC via ingenuity pathway analysis. The fetal mouse model not only exposes the genotoxic potential of vectors intended for gene therapy but can also reveal genes associated with liver oncogenesis.",
author = "Ali Nowrouzi and Cheung, {Wing T.} and Tingting Li and Xuegong Zhang and Anne Arens and Anna Paruzynski and Waddington, {Simon N.} and Emma Osejindu and Safia Reja and {Von Kalle}, Christof and Yoahe Wang and Faisal Al-Allaf and Lisa Gregory and Matthew Themes and Maxine Holder and Niraja Dighe and Alaine Ruthe and Buckley, {Suzanne M K} and Brian Bigger and Eugenio Montini and Thrasher, {Adrian J.} and Robert Andrews and Roberts, {Terry P.} and Newbold, {Robert F.} and Charles Coutelle and Manfred Schmidt and Mike Themis",
year = "2013",
month = "2",
doi = "10.1038/mt.2012.224",
language = "English",
volume = "21",
pages = "324--337",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis

AU - Nowrouzi, Ali

AU - Cheung, Wing T.

AU - Li, Tingting

AU - Zhang, Xuegong

AU - Arens, Anne

AU - Paruzynski, Anna

AU - Waddington, Simon N.

AU - Osejindu, Emma

AU - Reja, Safia

AU - Von Kalle, Christof

AU - Wang, Yoahe

AU - Al-Allaf, Faisal

AU - Gregory, Lisa

AU - Themes, Matthew

AU - Holder, Maxine

AU - Dighe, Niraja

AU - Ruthe, Alaine

AU - Buckley, Suzanne M K

AU - Bigger, Brian

AU - Montini, Eugenio

AU - Thrasher, Adrian J.

AU - Andrews, Robert

AU - Roberts, Terry P.

AU - Newbold, Robert F.

AU - Coutelle, Charles

AU - Schmidt, Manfred

AU - Themis, Mike

PY - 2013/2

Y1 - 2013/2

N2 - Genotoxicity models are extremely important to assess retroviral vector biosafety before gene therapy. We have developed an in utero model that demonstrates that hepatocellular carcinoma (HCC) development is restricted to mice receiving nonprimate (np) lentiviral vectors (LV) and does not occur when a primate (p) LV is used regardless of woodchuck post-translation regulatory element (WPRE) mutations to prevent truncated X gene expression. Analysis of 839 npLV and 244 pLV integrations in the liver genomes of vector-treated mice revealed clear differences between vector insertions in gene dense regions and highly expressed genes, suggestive of vector preference for insertion or clonal outgrowth. In npLV-associated clonal tumors, 56% of insertions occurred in oncogenes or genes associated with oncogenesis or tumor suppression and surprisingly, most genes examined (11/12) had reduced expression as compared with control livers and tumors. Two examples of vector-inserted genes were the Park 7 oncogene and Uvrag tumor suppressor gene. Both these genes and their known interactive partners had differential expression profiles. Interactive partners were assigned to networks specific to liver disease and HCC via ingenuity pathway analysis. The fetal mouse model not only exposes the genotoxic potential of vectors intended for gene therapy but can also reveal genes associated with liver oncogenesis.

AB - Genotoxicity models are extremely important to assess retroviral vector biosafety before gene therapy. We have developed an in utero model that demonstrates that hepatocellular carcinoma (HCC) development is restricted to mice receiving nonprimate (np) lentiviral vectors (LV) and does not occur when a primate (p) LV is used regardless of woodchuck post-translation regulatory element (WPRE) mutations to prevent truncated X gene expression. Analysis of 839 npLV and 244 pLV integrations in the liver genomes of vector-treated mice revealed clear differences between vector insertions in gene dense regions and highly expressed genes, suggestive of vector preference for insertion or clonal outgrowth. In npLV-associated clonal tumors, 56% of insertions occurred in oncogenes or genes associated with oncogenesis or tumor suppression and surprisingly, most genes examined (11/12) had reduced expression as compared with control livers and tumors. Two examples of vector-inserted genes were the Park 7 oncogene and Uvrag tumor suppressor gene. Both these genes and their known interactive partners had differential expression profiles. Interactive partners were assigned to networks specific to liver disease and HCC via ingenuity pathway analysis. The fetal mouse model not only exposes the genotoxic potential of vectors intended for gene therapy but can also reveal genes associated with liver oncogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84873391456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873391456&partnerID=8YFLogxK

U2 - 10.1038/mt.2012.224

DO - 10.1038/mt.2012.224

M3 - Article

C2 - 23299800

AN - SCOPUS:84873391456

VL - 21

SP - 324

EP - 337

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 2

ER -